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Abstract
Despite the fact that skeletal muscle insulin resistance is the hallmark of type-
2 diabetes mellitus (T2DM), inflexibility in substrate energy metabolism has
been observed in other tissues such as liver, adipose tissue, and heart. In the
heart, structural and functional changes ultimately lead to diabetic cardiomy-
opathy. However, little is known about the early biochemical changes that
cause cardiac metabolic dysregulation and dysfunction. We used a dietary
model of fructose-induced T2DM (10% fructose in drinking water for
6 weeks) to study cardiac fatty acid metabolism in early T2DM and related
signaling events in order to better understand mechanisms of disease. In early
type-2 diabetic hearts, flux through the fatty acid oxidation pathway was
increased as a result of increased cellular uptake (CD36), mitochondrial
uptake (CPT1B), as well as increased b-hydroxyacyl-CoA dehydrogenase and
medium-chain acyl-CoA dehydrogenase activities, despite reduced mitochon-
drial mass. Long-chain acyl-CoA dehydrogenase activity was slightly decreased,
resulting in the accumulation of long-chain acylcarnitine species. Cardiac
function and overall mitochondrial respiration were unaffected. However, evi-
dence of oxidative stress and subtle changes in cardiolipin content and com-
position were found in early type-2 diabetic mitochondria. Finally, we
observed decreased activity of SIRT1, a pivotal regulator of fatty acid metabo-
lism, despite increased protein levels. This indicates that the heart is no longer
capable of further increasing its capacity for fatty acid oxidation. Along with
increased oxidative stress, this may represent one of the earliest signs of dys-
function that will ultimately lead to inflammation and remodeling in the dia-
betic heart.
Introduction
Type-2 diabetes mellitus (T2DM) is the most prevalent form
of diabetes. Its pathogenesis is multi-factorial and is typically
characterized by a combination of insulin resistance
(impaired insulin-mediated glucose disposal) and aberrant
lipid metabolism, which consequently leads to accumulation
of triglycerides, mitochondrial dysfunction, oxidative stress,
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and inflammation (Boudina and Abel 2010). The clustering
of these conditions is often referred to as the metabolic syn-
drome, the manifestation of which is a major risk factor for
cardiovascular morbidity and mortality.
Consumption of fructose (high-fructose corn syrup) and
calorie-dense (sugar- and/or fat-enriched) food and bever-
ages is considered to be a main contributing factor to the
current diabetic and obesity epidemic. Due to the lipogenic
nature of fructose (Basciano et al. 2005), fructose feeding
resembles the nutritional overload seen with high-fat diets.
It is known to induce metabolic changes that are typical of
T2DM in rodents and humans alike. The fructose-fed rat, a
model of the metabolic syndrome originally described by
Zavaroni et al. (1980), exhibits fasting hyperglycemia,
hyperinsulinemia, insulin resistance, hypertriglyceridemia,
and arterial hypertension (Dai and McNeill 1995; Thor-
burn et al. 1989; Tran et al. 2009). The effects of fructose-
rich diets, particularly on insulin sensitivity, are time- and
tissue-dependent (Dai and McNeill 1995; Delbosc et al.
2005; Polakof et al. 2016) and appear to be reversible, at
least if feeding does not exceed 12 weeks (Dai and McNeill
1995). Rats receiving drinking water enriched with 10%
fructose for a period of 6 weeks are insulin resistant and
represent a valuable model for early stage T2DM, which we
have robustly replicated in all of our previous studies (Lou
et al. 2014, 2015; Warren et al. 2014). Our experience with
6-week fructose feeding in Sprague-Dawley rats showed
that insulin-stimulated glucose uptake was decreased in the
heart without overt signs of cardiac dysfunction (Lou et al.
2015). On the other hand, the skeletal muscle revealed
fiber-specific (glycolytic extensor digitorum longus vs.
oxidative soleus) differences in their respective onset of
metabolic derangements and oxidative stress, despite an
overall conserved mitochondrial function and capacity
(Warren et al. 2014). In this study, we aimed to character-
ize and elucidate the metabolic (mal)adaptations as well as
oxidative stress that occur in fructose-induced type-2 dia-
betic hearts at early stages of the disease. These events may
represent common factors leading to heart failure, and may
be integral parts of the primary mechanisms underlying
diabetic cardiomyopathy.
Materials and Methods
Chemicals
All chemicals were from Sigma–Aldrich (Oakville, ON,
Canada), unless otherwise stated.
Animals
All animal experiments were conducted in accordance to
the Guide for the Care and Use of Laboratory Animals
published by the National Institutes of Health (NIH pub-
lication, 8th ed., 2011) and was approved by the Univer-
sity of Alberta Animal Policy and Welfare Committee.
Male Sprague-Dawley rats at 6 weeks of age were housed
and maintained on a 12-h/12-h light/dark cycle and
allowed free access to standard rodent chow and either
water ad libitum (control group) or 10% fructose in the
drinking water (fructose-fed group) for 6 weeks, as previ-
ously done (Warren et al. 2014). Thereafter, glucose toler-
ance test and insulin sensitivity tests were performed by
serial measurements of blood glucose after intraperitoneal
injection of D-glucose (2 g/kg body weight) or subcuta-
neous injection of recombinant human insulin (0.5 U/kg
body weight; Novolinge Toronto, Novo Nordisk Canada
Inc, Mississauga ON, Canada).
Echocardiography
Echocardiography was performed in control and fructose-
fed rats after 6 weeks of feeding. Cardiac function was
assessed using echocardiography under light isoflurane
anesthesia, using a Vevo 770 high-resolution imaging sys-
tem equipped with a 30 MHz transducer (RMV-707B,
VisualSonics, Toronto, Canada).
Mitochondrial respirometric measurements
The whole left ventricle of the rat heart was excised for
mitochondrial isolation, using a modified method of King
et al. (2007). The final mitochondrial suspension was
immediately used for measurement of mitochondrial respi-
ratory parameters. Mitochondrial respirometry was mea-
sured using the Oroboros Oxygraph 2K system (Oroboros,
Innsbruck, Austria) at 37°C, in a similar manner as previ-
ously reported (Warren et al. 2014). The following sub-
strates were used to evaluate oxidative phosphorylation
driven by fatty acid oxidation substrates: palmitoylcarnitine
(2.5–15 lmol L1) + malate (4 mmol L1), palmitoyl-
CoA (20 lmol L1) + carnitine (1.25 mmol L1) +
malate (2 mmol L1), octanoylcarnitine (330 lmol
L1) + malate (2 mmol L1), acetylcarnitine (5 mmol
L1) + malate (2 mmol L1); state III (ADP-stimulated,
5 mmol L1) respiration or state IV (oligomycin-inhibited,
2 lg mL1) respiration. High concentrations of palmitoyl-
carnitine potentially have a detergent effect on the mito-
chondrial membranes, which suppresses mitochondrial
respiration (Cho and Proulx 1969), and so a palmitoylcar-
nitine titration was initially performed to identify the opti-
mal concentration for maximal respiration. A single
addition of this concentration was then applied to the
palmitoylcarnitine/malate protocol. Measurements with
complex-specific substrates were also performed: pyru-
vate (5 mmol L1) + malate (2 mmol L1), glutamate
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(40 mmol L1) + malate (8 mmol L1), succinate
(10 mmol L1) + rotenone (0.5 lmol L1), and ascorbate
(2 mmol L1) + N,N,N0,N0-tetramethyl-i-phenylenedia-
mine (TMPD, 0.5 mmol L1). Additional measurements of
mitochondrial respiration were made with cytochrome c
(10 lmol L1), in the presence and absence of pyruvate,
malate, and ADP. A cytochrome effect of <10% validates the
integrity of the outer mitochondrial membrane (Kuznetsov
et al. 2004). Final respirometry data were expressed as pmol
O/(s lg) mitochondria.
Enzymatic activity assays
Electron transport complex activities were determined as
specific donor-acceptor oxidoreductase activities using
mitochondrial samples that had undergone 3 cycles of
freeze/thaw in hypotonic buffer (25 mmol L1 potassium
phosphate/5 mmol L1 MgCl2, pH 7.2) (Kirby et al.
2007). Complex I activity was measured as rotenone-sen-
sitive oxidation of NADH (340 nm) with 65 lmol L1
ubiquinone as substrate (50 mmol L1 potassium phos-
phate pH 7.5, 2.5 mg mL1 defatted BSA, 130 lmol L1
NADH, 2 mmol L1 KCN, 10 lg mL1 antimycin A,
2 lg mL1 rotenone). Complex II activity was assessed as
malonate-sensitive reduction in 2,6-dichlorophenolindo-
phenol (DCPIP, 600 nm) with 20 mmol L1 succinate as
substrate (25 mmol L1 potassium phosphate pH 7.5,
1 mg mL1 defatted BSA, 50 lmol L1 DCPIP,
2 mmol L1 KCN, 10 lg mL1 antimycin A, 2 lg mL1
rotenone, 10 mmol L1 malonate, 65 lmol L1 ubiqui-
none). Complex III activity was determined as antimycin
A-sensitive reduction in cytochrome c (550 nm) with
200 lmol L1 decylubiquinol as substrate (25 mmol L1
potassium phosphate pH 7.5, 1 mmol L1 n-dodecyl-b-
D-maltoside, 2 lg mL1 rotenone, 1 mmol L1 KCN,
100 lmol L1 EDTA, 75 lmol L1 oxidized cytochrome
c, 10 lg mL1 antimycin A). Complex IV activity was
measured as the oxidation of reduced cytochrome c
(550 nm) under conditions: 50 mmol L1 potassium
phosphate pH 7.0, 450 lmol L1 n-dodecyl-b-D-malto-
side, 1 mmol L1 KCN, 100 lmol L1 reduced cyto-
chrome c. All assays were performed at 30°C. Carnitine
palmitoyltransferase (CPT) activity was measured in
mitochondrial samples using 5,50-dithiobis-(2-nitroben-
zoic acid) (DTNB) to monitor the release of reduced CoA
liberated from palmitoyl-CoA by CPT at 412 nm, as pre-
viously described (Lou et al. 2014). b-hydroxyacyl-CoA
dehydrogenase (b-HCAD) activity of mitochondrial iso-
lates was measured in buffer containing 97 mmol L1
potassium phosphate, and 100 lmol L1 NADH, pH 7.3.
The reaction was started with 90 lmol L1 S-acetoacetyl-
CoA and the oxidation of NADH was monitored at
430 nm for 5 min. Acyl-CoA dehydrogenase activities
were assayed in mitochondrial isolates by monitoring the
bleaching of DCPIP at 600 nm, using either octanoyl-
CoA (medium-chain) or palmitoyl-CoA (long-chain) as
substrate (Ikeda et al. 1983). Aldehyde dehydrogenase-2
(ALDH2) activity was determined from mitochondrial
isolates, by monitoring the reduction in NAD+ to NADH
(340 nm) at room temperature, in 50 mmol L1 sodium
pyrophosphate pH 9.5, 10 mmol L1 acetaldehyde, and
2.5 mmol L1 NAD+. Aconitase activity was measured in
mitochondria that were isolated in the presence of citrate
and MnCl2, to limit aconitase inactivation during sample
preparation and storage (Gardner et al. 1994; Bulteau
et al. 2003). Aconitase activity was assayed as previously
outlined (Lou et al. 2014). Oxalomalate (2 mmol L1,
Cayman), a competitive inhibitor of aconitase, was
included in a separate set of samples to ensure assay
specificity. The activity of citrate synthase (CS), was spec-
trophotometrically monitored in tissue homogenates by
following the formation of thionitrobenzoate (TNB) at
412 nm under the following conditions: 100 mmol L1
Tris-HCl (pH 8.1), 0.1 mmol L1 DTNB, 0.5 mmol L1
oxaloacetate, 0.31 mmol L1 acetyl CoA, 0.25% Triton X-
100, as previously described (Srere 1969). NF-kB (p65)
DNA-binding activity was assayed using nuclear fraction
prepared as recommended by the manufacturer (Thermo
Scientific). The activities of pyruvate dehydrogenase
(PDH), SIRT1, and SIRT3 activities were measured using
kits purchased from Abcam. Superoxide dismutase (SOD)
activity was measured according to manufacturer’s specifi-
cations (BioVision Incorporated, CA). The following mea-
surements were performed according to respective
manufacturer’s instructions: glutathione (BioVision), mal-
onyl-CoA (MyBiosource), NAD+/NADH and NADP+/
NADPH (Abcam).
Subcellular fractionations
Subcellular fractionations of mitochondria, nuclear and
sarcolemma by differential centrifugation were performed
according to the methods of Cox and Emili (2006). Pro-
tein concentrations were quantified by Bradford assay.
Immunoblotting
Total tissue homogenates were prepared using lysis buffer
(50 mmol L1 Tris pH 8.0, 150 mmol L1 NaCl, 1% NP-
40, 0.1% SDS, 0.5% sodium deoxycholate) supplemented
with the appropriate protease and phosphatase inhibitors.
Protease and phosphatase inhibitors were also included in
the solutions used in the preparation of subcellular frac-
tionations for immunoblotting. All prepared tissue homo-
genates or subcellular fractions were mixed in 5X SDS
loading buffer for Western blot analyses. Equal amounts
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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of protein samples were loaded, separated by SDS-PAGE
and transferred to nitrocellulose membranes for
immunoblotting with indicated antibodies. Immuno-reac-
tivity was visualized by an ECL reaction (GE HealthCare),
and its intensity was quantified using ImageJ software
(http://rsbweb.nih.gov/ij/). The following primary anti-
bodies were sourced from (1) Cell Signaling Technology
(Danvers, MA): pan-acetyl-lysine (#9441), phospho-
AMPKa (Thr172; #2531), AMPKa (#2532), lamin A/C
(#4777), Na+/K+-ATPase (#3010), (2) Abcam Inc. (Cam-
bridge, MA): CD36 (#ab133625), COX IV (#ab14744),
CPT1B (#ab104662), PDK4 (#ab89295), PGC1a
(#ab54481), PPARa (#ab8934), a-tubulin (#ab7291); (3)
Santa Cruz Biotechnology Inc. (Dallas, TX): SIRT1 (#sc-
15404), SIRT3 (#sc-99143); (4) Millipore (San Diego,
CA): HNE-Michael adducts (#393207); (5) Acris Antibod-
ies (San Diego, CA): glutathione peroxidase I (GPx1;
#AP32028PU-N); (6) Thermo Scientific (Rockford):
thioredoxin reductase 2 (TrxR2; #PA1-20940).
Transmission electron microscopy
Left ventricular biopsies were prefixed in 2.5% glutaralde-
hyde in 0.1 mol L1 sodium cacodylate buffer, postfixed
in 2% osmium tetroxide (OsO4) in 0.1 mol L
1 sodium
cacodylate buffer, dehydrated in ethyl alcohol, and
embedded in epoxy resin. Ultra thin-sections (60 nm)
were cut using an ultramicrotome (Leica UC7, Leica
Microsystems Inc., ON, Canada), stained with 4% uranyl
acetate and Reinold’s lead citrate and imaged under a
Hitachi H-7650 transmission electron microscope at
80 kV equipped with a 16 megapixel EMCCD camera
(XR111, Advanced Microscopy Technique, MA). Photo-
shop (Adobe) was used to adjust contrast and brightness
of transmission electron micrographs, trace mitochondrial
boundaries on the micrographs, and color the traced
areas. The colored areas which represent mitochondrial
mass were quantified by ImageJ software.
Mass spectrometry for cardiolipin analysis
and acylcarnitine profiling
Lipids were extracted from cardiac tissue samples using a
mixed methanol-chloroform (3:1, v/v) solvent twice. Lipid
extracts were dried under a nitrogen gas flow at 30°C.
The dried residues were dissolved in methanol (12.5 lL
per mg of the raw material). UPLC-MS runs were carried
out on a Waters Acquity UPLC system coupled to a
Thermo Scientific LTQ-Orbitrap Fusion Fourier trans-
form (FT) mass spectrometer with positive-ion (+) elec-
trospray ionization. The MS instrument was operated in
the (+) ion survey scan mode with Fourier transform
(FT) MS detection (a 120,000-mass resolution at m/z
400) for separation and detection of cardiolipin (CL) spe-
cies. Separation of cardiolipins from other lipids was per-
formed on a silica-based hydrophilic interaction liquid
chromatography (HILIC) column and with methanol –
ammonium acetate buffer as the mobile phase for binary
solvent gradient elution, using a custom-developed proce-
dure. Tetramyristoyl-cardiolipin (CL[56:0]) and tetrao-
leoyl-cardiolipin (CL[72:4]) were purchased from Avanti
Polar Lipids, Inc. (Alabaster) and used as internal stan-
dard (IS). Tissue levels of acylcarnitine species were mea-
sured using electrospray ionization tandem mass
spectrometry. Acylcarnitines were extracted from heart
tissue with methanol and quantified using eight isotopi-
cally labeled internal standards (Cambridge Isotopes Lab-
oratories, Andover, MA). Precursor ions of m/z 85 in the
mass range of m/z 150–450 were acquired on a PE SCIEX
API 365 LC-ESI-MS/MS instrument (Applied Biosystems,
Foster City, CA).
Statistical analysis
SigmaPlot 13.0 (Systat Software, San Jose, CA) was used
for statistical analyses. Results are presented as
mean  SE for the indicated number of independent
heart experiments. Differences between control and
fructose-fed rats were evaluated by Student’s t-test or
Mann–Whitney rank sum tests, as determined by data
distribution. Differences are considered significant when
P < 0.05.
Results
Insulin resistance but normal cardiac
function in hearts of early type-2 diabetic
fructose-fed rats
After 6 weeks of fructose feeding, rats were hyper-
glycemic, hyperinsulinemic, and showed delayed whole
body glucose clearance (Table 1). The hearts of fructose-
fed rats were insulin resistant as evidenced by the reduc-
tion in pyruvate dehydrogenase (PDH) activity (Table 2),
the rate-limiting enzyme for glucose oxidation, and
increased expression of PDH kinase 4 (PDK4) (Fig. 1A).
These results are consistent with our previous experi-
ments showing decreased activation of downstream sig-
naling (such as Akt) upon insulin stimulation and
significant reduction in insulin-stimulated glucose uptake
(Lou et al. 2015). At this early stage of insulin resistance,
there were no signs of cardiac dysfunction (Table 3) or of
cardiac hypertrophy (no increase in atrial natriuretic pep-
tide and a-skeletal muscle actin protein levels, data not
shown), confirming previous observations (Calabro et al.
2016).
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Mitochondrial fatty acid oxidation capacity
is increased in hearts of early type-2
diabetic fructose-fed rats
Levels of nuclear PPARa and PGC1a that transactivate
multiple genes involved in myocardial fatty acid utiliza-
tion were enhanced in hearts of fructose-fed rats
(Fig. 1A). In addition, the abundance of CD36 and
AMPK activity (p-AMPK), which are involved in the cel-
lular uptake of fatty acids, were also increased (Fig. 1A).
In contrast, the activity of CPT1, a key determinant of
mitochondrial fatty acid uptake capacity, was reduced in
hearts of fructose-fed rats (Table 2). However, the
myocardial concentration of malonyl-CoA (a potent inhi-
bitor of CPT1) was lower in hearts of fructose-fed rats
(Fig. 1B) and this, in combination with the twofold
increase in the half-maximal inhibitory concentration
(IC50) of malonyl-CoA on CPT1 activity (Fig. 1C) indi-
cates that CPT1 activity was overall less inhibited at any
malonyl-CoA concentration in hearts of fructose-fed rats
compared with age-matched controls. Hence, cardiac
mitochondria from fructose-fed rats experience an
Table 1. Effects of fructose feeding on metabolic parameters.
C FF P value
Plasma fasting
glucose (mg dL1)
95 (78; 97) 124 (123; 136) 0.008
Plasma fasting
insulin (ng mL1)
1.066  0.21 2.69  0.17 0.0003
QUICKI 0.295  0.007 0.250  0.002 0.0004
Plasma triglycerides
(mg mL1)
62 (58; 90) 341 (279; 487) <0.001
GTT-AUC
(mmol L1 min1)
1053  63 1569  40 0.0001
IST-AUC
(mmol L1 min1)
452 (439; 457) 717 (686; 802) 0.008
Data are presented as mean  SE or median (25th; 75th percentile).
n = 5 (all parameters, except plasma triglycerides), n = 10
(triglycerides). Bold indicates the results significant at the 0.05 level.
C, age-matched control rats (fed standard chow and water); FF,
rats fed standard chow and 10% fructose added to the drinking
water; AUC, area-under-the-curve; GTT, glucose tolerance test;
IST, insulin sensitivity test; QUICKI, quantitative insulin sensitivity
check index.
Table 2. Enzymatic activities.
C FF n P value
Mitochondrial complex
Complex I (lmol min1 mg1) 0.58  0.03 0.71  0.04 8 0.021
Complex II (lmol min1 mg1) 0.17  0.01 0.13  0.01 8 0.052
Complex III (lmol min1 mg1) 4.00  0.31 4.38  0.32 8 0.410
Complex IV (lmol min1 mg1) 6.31  0.50 5.27  0.26 8 0.085
CPT activity
CPT total (lmol min1 g1) 13.14  0.55 14.45  1.31 7 0.372
CPT 2 (lmol min1 g1) 7.93  0.72 11.75  1.11 7 0.013
CPT 1 (lmol min1 g1) 5.21  0.18 2.71  0.60 7 0.002
b-Oxidation
LCAD (nmol min1 mg1) 9.93  0.42 8.27  0.30 6 0.009
MCAD (nmol min1 mg1) 3.15  0.23 4.35  0.18 6 0.002
b-HCAD (nmol min1 mg1) 3.18  0.34 4.31  0.32 8 0.029
Other
Aconitase (lmol min1 mg1) 96.4  9.4 46.1  4.8 8 0.0005
ALDH2 (nmol min1 mg1) 626  83 263  42 6 0.003
Citrate Synthase (lmol min1 mg1) 0.96  0.03 0.81  0.02 6 0.003
PDH activity (mOD min1 CS1) 100.9  4.6 83.4  4.4 7 0.017
SOD, mitochondrial (U mg1) 3.87  0.54 3.07  0.24 6 0.244
SOD, cytosolic (U mg1) 203  13 228  21 6 0.339
Data are presented as mean  SE. Bold indicates the results significant at the 0.05 level.
C, age-matched control rats (fed standard chow and water); FF, rats fed standard chow and 10% fructose added to the drinking water;
b-HCAD, b-hydroxyacyl-CoA dehydrogenase; MCAD, acyl-CoA dehydrogenase, medium chain; LCAD, acyl-CoA dehydrogenase, long chain;
ALDH2, aldehyde dehydrogenase-2; CPT, carnitine palmitoyltransferase; CS, citrate synthase; PDH, pyruvate dehydrogenase; SOD, superoxide
dismutase.
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increased influx of long-chain fatty acids. In agreement
with these data, mitochondrial oxygen consumption
under State 3 respiration (in the presence of ADP) with
palmitoyl-CoA as substrate was higher in hearts of fruc-
tose-fed rats, while it was similar with palmitoylcarnitine
(Table 4). State 3 mitochondrial oxygen consumption
with octanoylcarnitine as substrate was also higher
(Table 4), consistent with increased b-HCAD (b-hydro-
xyacyl-CoA dehydrogenase) and MCAD (medium-chain
acyl-CoA dehydrogenase) activities (Table 2). LCAD
(long-chain acyl-CoA dehydrogenase) activity was slightly
but significantly reduced in hearts of fructose-fed animals
(Table 2), consistent with accumulation of long-chain
acylcarnitines (Table 5).
Mitochondrial respiration is preserved
despite reduced mitochondrial content in
hearts of early type-2 diabetic fructose-fed
rats
Citrate synthase (CS) activity, a measure of mitochondrial
content and oxidative capacity, was significantly reduced in
hearts of fructose-fed rats (Table 2). Moreover, the protein
levels of the mitochondrial marker complex IV were also
lower in hearts of fructose-fed rats (Fig. 1A). These data
were corroborated by electron microscopy showing a
reduced mitochondrial mass in hearts of fructose-fed rats
(Fig. 2A). In contrast, mitochondrial respiratory activity
determined during active oxidative phosphorylation (State
3, in the presence of ADP) supported by pyruvate/malate,
glutamate/malate, succinate and ascorbate/TMPD were not
different between groups, indicative of no change in respi-
ratory capacity per mitochondrial protein mass (Table 4).
Oligomycin-induced State 4 respiration (proton leak or
nonphosphorylating respiration) using pyruvate/malate,
glutamate/malate, succinate and ascorbate/TMPD, or fatty
acid substrates, was not different between hearts of age-
matched control and fructose-fed rats. There was no
indication of enhanced mitochondrial proton leak or
uncoupling. The respiratory control ratio (State 3/State 4
ratio), indicative of the coupling efficiency between sub-
strate oxidation and ATP synthesis, was unaffected in
hearts of fructose-fed rats. The respirometric (complex IV-
driven substrate ascorbate/TMPD; Table 4) and the enzy-
matic assay (Table 2) suggest that cardiac complex IV
activity is preserved in hearts of fructose-fed rats. However,
subtle changes in complex I and complex II enzymatic
activities were detected (Table 2).
Figure 1. Increased cellular and mitochondrial fatty acid uptake in hearts of fructose-fed rats. (A) Representative immunoblots and
densitometric quantification of cellular AMPK, PDK4, CPT1B, and COX IV, nuclear PPARa and PGC1a, and plasma membrane CD36 (n = 6–7/
group). (B) Malonyl-CoA content from total cardiac tissue samples (n = 7/group). (C) Semi-logarithmic plot of CPT activity at graded malonyl-
CoA concentrations (0, 0.05, 0.1, 0.5, 1, 5, 10, and 1000 lmol L1; n = 7/group), with averaged IC50 values calculated from independent
plots for each heart in each independent treatment group. Data were normalized to mitochondrial protein concentration. Results are
mean  SE. C, control rats; FF, fructose-fed rats; AMPK, 50 AMP-activated protein kinase; CD36, fatty acid translocase; COX IV, complex IV
(cytochrome c oxidase); CPT, carnitine palmitoyltransferase; PDK4, pyruvate dehydrogenase kinase 4; PPARa, peroxisome proliferator-activated
receptor alpha; PGC1a, peroxisome proliferator-activated receptor gamma coactivator 1-alpha.
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The content of cardiolipin, which is found almost
exclusively in the inner mitochondrial membrane, where
it is essential for the optimal function of numerous
enzymes involved in mitochondrial energy metabolism,
was similar in cardiac mitochondria from age-matched
control and fructose-fed rats (Table 6). However, alter-
ations in cardiolipin composition were observed
(Fig. 2B). In particular, cardiolipin species containing
saturated fatty acyl chains were increased in hearts of
fructose-fed rats. For example, the cardiolipin cluster with
68 carbons accounted for 0.4% (0.03%; 0.04%) of the
total cardiolipin in cardiac mitochondria from age-
matched control rats, but this tended to be higher (0.8%
[0.05%; 0.13%], P = 0.056) in cardiac mitochondria from
fructose-fed rats. Identification of molecular isoforms
revealed that both single cardiolipin species (cardiolipin
Table 3. Echocardiography.
C FF P value
M-mode left ventricular internal diameter trace (LV Mass Protocol)
HR (min1) 344  13 380  24 0.205
LVID;d (mm) 7.9  0.5 7.7  0.5 0.761
LVID;s (mm) 3.6 (2.8; 5.3) 3.7 (3.1; 4.0) 0.905
Vol;d (mm3) 342  45 320  40 0.735
Vol;s (mm3) 78  24 56  9 0.485
SV (mm3) 265  21 264  34 0.987
EF (%) 82 (70; 88) 82 (79; 86) 0.905
FS (%) 52 (41; 60) 52 (50; 57) 0.905
CO (mm3/min) 91  9 100  14 0.592
Cardiac geometry
IVS;d (mm) 2.2 (2.1; 2.2) 2.1 (2.1; 2.5) 0.548
IVS;s (mm) 3.6 (3.4; 3.6) 3.5 (3.5; 4.2) 1.000
LVPW;d (mm) 2.1  0.1 2.4  0.1 0.076
LVPW;s (mm) 3.4  0.2 3.7  0.2 0.431
LVID;d (mm) 7.8  0.4 8.0  0.4 0.829
LVID;s (mm) 4.1  0.5 4.0  0.3 0.855
LV Mass (g) 1103  97 1278  127 0.305
Mitral tissue doppler measures
E/A 1.31  0.10 1.26  0.09 0.704
DS (mm/sec2) 24 (17; 30) 30 (17; 50) 0.548
IVRT (msec) 27.0  0.9 26.4  1.8 0.375
IVCT (msec) 19.3  1.0 19.5  1.3 0.895
ET (msec) 56.3  2.3 58.0  3.4 0.344
TEI index 0.83  0.03 0.80  0.05 0.637
E’/A’ 0.98  0.06 1.06  0.02 0.196
E/E’ 18.3  1.8 22.6  5.2 0.461
S’ 54.5  2.0 48.0  2.2 0.060
Pulmonary venous flow profile
s-wave (mm/sec) 267  16 257  12 0.624
d-wave (mm/sec) 520  23 593  66 0.377
a-wave (mm/sec) 143  18 199  27 0.152
PVad (msec) 17.8  0.8 20.2  2.1 0.366
Other
Desc AoV (mm/sec) 1048  31 853  48 0.026
Asc AoV (mm/sec) 1203 (1115; 1358) 1061 (1018; 1365) 0.250
Data are presented as mean  SE or median (25th percentile; 75th percentile); n = 5 per group. Bold indicates the results significant at the
0.05 level.
d, diastole; s, systole; HR, heart rate; LVID, left ventricular interrior diameter; Vol, volume; SV, stroke volume; EF, ejection fraction; FS, frac-
tional shortening; CO, cardiac output; IVS, interventricular septum; LVPW, left ventricle posterior wall thickness; LVID, left ventricular interrior
diameter; E, peak early diastolic left ventricular (LV) inflow velocity; A, late diastolic LV inflow velocity; E/A, ratio of early to late LV diastolic fill-
ing velocities; DS, deceleration slope of the E wave; IVRT, isovolumic relaxation time; IVCT, isovolumic contraction time, ET, ejection time, TEI
index, myocardial performance index, calculated as [IVCT + IVRT]/ET; E’, peak early diastolic velocity at the mitral annulus; A’, late diastolic LV
inflow velocity at the mitral annulus; S’, systolic velocity at the mitral annulus; PVad, pulmonary venous a-wave duration; Desc AoV, descend-
ing aorta pulse wave velocity; Asc AoV, ascending aorta pulse wave velocity.
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[68:2] identified as C16:0/C16:0/C18:1/C18:1) or mixtures
of different isomers were present, such as cardiolipin
(68:5) containing C16:0/C16:1/C18:2/C18:2, C16:1/C16:1/
C18:1/C18:2, and C14:0/C18:1/C18:1/C18:2. No oxidized
cardiolipins were detected.
Evidence of oxidative stress in hearts of
early type-2 diabetic fructose-fed rats
Mitochondrial 4-hydroxynonenal (HNE), which constitutes
one of the most reactive aldehydes that are generated within
a pathological milieu such as diabetes (Roede and Jones
2010), was higher in hearts of fructose-fed rats (Fig. 3A). In
addition, the activity of ALDH2, a key enzyme involved in
HNE metabolism and a cellular defense mechanism against
HNE toxicity, was reduced in hearts of fructose-fed rats
(Table 2) despite similar protein levels (data not shown).
Accordingly, the activity of mitochondrial aconitase (a TCA
cycle enzyme susceptible to oxidative stress) was lower in
hearts of fructose-fed rats (Table 2). Ratios of GSH:GSSG
(Fig. 3B) and NADPH:NADP+ (Fig. 3C), key indices of the
redox status, were reduced. Protein levels of glutathione per-
oxidase (GPx1) were lower and those of thioredoxin reduc-
tase (TrxR2) were higher in hearts from fructose-fed rats
(Fig. 3A). The activities of mitochondrial and cytosolic SOD
were unchanged (Table 2).
Sirtuin expression and activity in hearts of
early type-2 diabetic fructose-fed rats
In hearts of fructose-fed rats, nuclear SIRT1 protein levels
were increased (Fig. 4A) but SIRT1 activity was reduced as
compared to control hearts (Fig. 4C). The reduced SIRT1
activity was mirrored in the observed increase in global
nuclear protein acetylation (Fig. 4C). Reduced activity of
SIRT1 is accompanied by NF-jB activation (Fig. 4B) and
may drive inflammation in hearts from fructose-fed rats.
Finally, there was no difference in the NAD+/NADH ratio
(an important determinant of sirtuin activity) in the nuclear
fraction (Fig. 4D). A similar dissociation between protein
abundance and activity levels was also observed with regard
to mitochondrial SIRT3. Despite a doubling in SIRT3
protein abundance (Fig. 5A) and NAD+/NADH ratio
(Fig. 5C) in hearts of fructose-fed rats, SIRT3 activity within
the mitochondrial fraction was unchanged compared with
hearts from age-matched rats (Fig. 5D). The lack of SIRT3
activation was corroborated by the absence of changes in
global mitochondrial protein acetylation (Fig. 5B).
Discussion
In this study, we investigated the early molecular events
associated with cardiac insulin resistance in the fructose-
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induced T2DM rat model. Furthermore, we studied
whether fructose feeding for 6 weeks in the rat would
lead to cardiac mitochondrial dysfunction as previously
reported in other animal models (Boudina and Abel
2010; Buchanan et al. 2005). Our data show a clear pat-
tern of altered substrate utilization characterized by (1)
reduced PDH activity (2) increased sarcolemmal (CD36)
and mitochondrial fatty acid uptake (CPT1B), (3)
increased State 3 respiration with fatty acid substrates,
(4) increased MCAD and b-HCAD activities, and (5)
increased nuclear expression of PPARa and PGC1a, all
consistent with predominant reliance of cardiac metabo-
lism on fatty acid utilization.
Over-reliance on fatty acid oxidation in the diabetic
heart has been consistently observed in many experimen-
tal models of T2DM (Boudina and Abel 2010; Buchanan
et al. 2005; Carley and Severson 2005; Mazumder et al.
2004; Wang et al. 2005, 2015) and has been linked to the
activation of PPARa and its coactivator PGC1a (Duncan
et al. 2007; Finck et al. 2002; Wright et al. 2009). The
upregulation of PPARa and PGC1a seen in our study
confirms observations by Duncan et al. (2007) and drives
the transcription of genes involved in fatty acid metabo-
lism (such as CD36, CPT1, MCAD) in order to cope with
excess provision of lipids from the circulation, and of
PDK4 (Wende et al. 2005), which further suppresses glu-
cose oxidation by decreasing PDH activity (Wu et al.
1998). PDH is an important metabolic control point
where the competition between carbohydrates and fatty
acids as metabolic substrates is rapidly regulated in the
heart (Lopaschuk et al. 2010). It has been recently recog-
nized that the increase in PDK4 protein levels is
Table 5. Concentrations of carnitine and acylcarnitine species in cardiac tissue of healthy control and fructose-fed rats.
Acylcarnitine species C FF P value
Free carnitine [C0] 424  22 492  36 0.122
Acetylcarnitine [C2] 375  40 491  15 0.053
Propionylcarnitine [C3] 1.7  0.2 2.4  0.3 0.064
Butyrylcarnitine [C4] 0.8  0.1 1.1  0.2 0.115
3-OH-Butyrylcarnitine/Malonylcarnitine 1.2  0.1 1.9  0.1 0.005
Isovalerylcarnitine [C5] 0.44 (0.37; 0.47) 0.57 (0.42; 0.79) 0.114
Tiglylcarnitine [C5:1] 0.11  0.01 0.13  0.02 0.327
Hexanoylcarnitine [C6] 0.78  0.07 0.90  0.11 0.366
Methylmalonylcarnitine [C4-DC] 3.2  0.3 3.9  0.3 0.217
Glutarylcarnitine [C5-DC] 0.17 (0.14; 0.19) 0.20 (0.15; 0.26) 0.476
Methylglutarylcarnitine [C6-DC] 0.05  0.005 0.06  0.008 0.111
Octanoylcarnitine [C8] 0.27  0.01 0.34  0.02 0.027
Octenoylcarnitine [C8:1] 0.05  0.01 0.04  0.01 0.455
Decanoylcarnitine [C10] 0.12  0.01 0.19  0.04 0.090
Decenoylcarnitine [C10:1] 0.04  0.01 0.04  0.01 0.911
Lauroylcarnitine [C12] 0.28  0.02 0.41  0.08 0.101
Laureoylcarnitine [C12:1] 0.21  0.02 0.30  0.05 0.061
Myristdienoylcarnitine [C14:2] 0.20 (0.19; 0.24) 0.32 (0.26; 0.61) 0.019
Myristeoylcarnitine [C14:1] 0.39  0.02 0.82  0.18 0.019
Myristoylcarnitine [C14] 1.04  0.07 1.57  0.26 0.043
3-OH-Myristoylcarnitine [C14-OH] 0.29  0.03 0.34  0.02 0.265
3-OH-Myristeoylcarnitine [C14:1-OH] 0.36  0.05 0.53  0.05 0.057
Palmiteoylcarnitine [C16:1] 2.0 (1.9; 2.2) 4.7 (3.0; 5.8) 0.010
Palmitoylcarnitine [C16] 6.1  0.4 8.1  1.3 0.110
3-OH-Palmitoylcarnitine [C16-OH] 1.2  0.2 1.5  0.02 0.294
3-OH-Palmiteoylcarnitine [C16:1-OH] 0.89  0.10 1.44  0.04 0.003
Linoleoylcarnitine [C18:2] 6.9 (4.7; 8.5) 7.7 (7.1; 15.6) 0.476
Oleoylcarnitine [C18:1] 12.3  0.8 19.0  2.4 0.014
Stearoylcarnitine [C18] 1.58  0.09 1.97  0.23 0.100
3-OH-Stearoylcarnitine [C18-OH] 0.21  0.03 0.22  0.02 0.708
3-OH-Oleoylcarnitine [C18:1-OH] 1.93  0.30 2.61  0.23 0.143
Total acylcarnitines 420  41 557  44 0.037
Values represent the acylcarnitine content expressed in nmol/g protein (n = 6 for C and n = 4 for FF). Data are presented as mean  SE or
median (25th percentile; 75th percentile). Bold indicates the results significant at the 0.05 level.
C, age-matched control rats (fed standard chow and water); FF, rats fed standard chow and 10% fructose added to the drinking water.
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extremely rapid and occurs within the first day when
feeding mice a high-fat diet (Crewe et al. 2013, 2017).
Likewise, the turnover of malonyl-CoA, the allosteric
inhibitor of CPT1, is very rapid in the heart (Reszko et al.
2001), given the high expression of acetyl-CoA carboxy-
lase (responsible for its synthesis) and malonyl-CoA
decarboxylase (responsible for its degradation). In addi-
tion, high levels of circulating fatty acids may be also
responsible for the increased activity of AMPK, which in
turn inhibits acetyl-CoA carboxylase, leading to reduced
malonyl-CoA synthesis as originally reported by Clark
et al. (2004). Alternatively, the observed reduced malonyl-
CoA levels could be explained by increased activity of
malonyl-CoA decarboxylase, which is a known PPARa
target (Campbell et al. 2002) and has been reported to be
responsible for the increased fatty acid utilization in type-
1 diabetic hearts (Sakamoto et al. 2000).
Cardiac insulin resistance (reduced glucose uptake,
blunted Akt-mediated insulin signaling, AMPK activation)
is one of the earliest observed defects in mice fed with
high-fat diet and develops after only 10 days, well in
advance of other metabolic organs such as skeletal mus-
cle, adipose tissue, and liver (Park et al. 2005). As in
genetic models of type-2 diabetes (ob/ob and db/db mice),
PPARa activation and related changes in expression levels
of PPARa targets such as PDK4 or MCAD appear only
after 5 weeks (Buchanan et al. 2005; Wright et al. 2009).
Hence, the molecular changes observed in hearts from
rats fed fructose-enriched water for 6 weeks suggest that
the initial stage of “feedforward” activation of b-oxidation
has been replaced by a chronic PPARa-driven increase in
flux through this pathway.
Overall mitochondrial oxidative phosphorylation per
mitochondrial mass was not compromised by fructose
feeding. Moreover, respiration was increased when using
fatty acids substrates, indicating enhanced fatty acid oxi-
dation. In humans, long-standing diabetes has been asso-
ciated with mitochondrial dysfunction (Anderson et al.
2009a; Croston et al. 2014; Montaigne et al. 2014), but
animal models yielded conflicting findings. Kuo et al.
(1985) showed impaired state 3 respiration of mitochon-
dria isolated from type-2 diabetic db/db mouse hearts oxi-
dizing pyruvate, a defect that was linked to decreased
PDH activity. The authors further showed that there was
no difference in respiration, when using palmitoylcar-
nitine as substrate and the activity of both b-hydroxyacyl-
Figure 2. Changes in mitochondrial mass and cardiolipin pattern in hearts of fructose-fed rats. (A) Reduced mitochondrial mass in hearts of
fructose-fed rats. Representative transmission electron microscopy (TEM) images at 30009 magnification of heart sections and analysis of
mitochondrial mass (n = 5 at 15009 or 30009 magnification per group). Results are mean  SE. C, control rats; FF, fructose-fed rats. (B)
Relative amounts of cardiolipin (CL) species in hearts of control and fructose-fed rats (n = 6/group). Data are presented as mean  SE.
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Table 6. Major (>1% abundance) cardiolipin fatty acyl molecular species detected in mitochondrial membranes from healthy control and fruc-
tose-fed rats.
CL(CN:DB) CL molecular species C FF P value
CL(54:6) C18:2/C18:2/C18:2/0:0 (monolysocardiolipin; L3-MLCL) 0.06  0.002 0.04  0.005 0.019
CL(70:6) C16:1/C18:2/C18:1/C18:2 0.06 (0.04; 0.06) 0.17 (0.10; 0.22) 0.002
CL(70:7) C16:1/C18:2/C18:2/C18:2 0.08  0.01 0.29  0.05 0.003
CL(72:7) C18:2/C18:2/C18:1/C18:2 (tri-linoleoyl-oleoyl-cardiolipin; L3O) 1.90  0.14 1.56  0.13 0.113
CL(72:8) C18:2/C18:2/C18:2/C18:2 (tetralinoleoyl cardiolipin; L4) 3.42  0.31 2.60  0. 0.046
CL(72:9) C18:2/C18:3/C18:2/C18:2 0.07  0.004 0.04  0.007 0.025
CL(74:8) C18:1/C18:2/C18:2/C20:3; C18:1/C18:2/C18:1/C20:4 0.11 (0.11; 0.13) 0.13 (0.08; 0.16) 0.937
CL(74:9) C18:2/C18:2/C18:2/C20:3 (major); C18:1/C18:2/C18:2/C20:4 0.19 (0.01) 0.22 (0.02) 0.279
CL(74:10) C18:2/C18:3/C18:2/C20:3; C18:2/C18:2/C18:2/C20:4;
C18:2/C20:4/C18:2/C22:6
0.13 (0.12; 0.16) 0.10 (0.08; 0.13) 0.065
CL(76:11) C18:1/C18:2/C18:2/C22:6; C16:0/C18:2/C20:4/C22:5;
C16:0/C18:2/C20:3/C22:6
0.11 (0.10; 0.15) 0.09 (0.05; 0.11) 0.093
CL(76:12) C18:2/C18:2/C18:2/C22:6 (major); C18:1/C18:1/C20:4/C22:6 0.12 (0.11; 0.18) 0.07 (0.03; 0.11) 0.026
Total content All species, including low abundance species 6.16  0.42 5.49  0.38 0.268
Values represent the molecular species content expressed in nmol/mg protein and are presented as mean  SE or median (25th; 75th per-
centile). n = 6 hearts per group. Bold indicates the results significant at the 0.05 level.
C, age-matched control rats (fed standard chow and water); FF, rats fed standard chow and 10% fructose added to the drinking water; CL,
cardiolipin; CN, carbon number of all 4 acyl chains; DB, number of double bonds on all 4 acyl chains.
Figure 3. Increased oxidative stress in hearts of fructose-fed rats. (A) Representative immunoblots and densitometric quantification of
mitochondrial 4-hydroxynonenal (HNE), mitochondrial thioredoxin reductase (TrxR2), and cellular glutathione peroxidase 1 (GPx1) (n = 6–7/
group). (B) Concentrations of reduced glutathione (GSH) and oxidized glutathione (GSSG) in cardiac homogenates of control and fructose-fed
rats, with their respective GSH:GSSG ratio (n = 10/group). (C) Concentrations of NADPH and NADP+ in cardiac mitochondria of control and
fructose-fed rats, with their respective NADPH/NADP+ ratio (n = 8/group). Data are presented as mean  SE. #Mann–Whitney nonparametric
statistical test was applied. C, control rats; FF, fructose-fed rats.
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CoA dehydrogenase and of b-ketothiolase (a and b sub-
unit of the mitochondrial trifunctional protein, respec-
tively) were not altered by diabetes. Likewise, reduced
mitochondrial respiration has been reported both in db/
db mouse hearts (Boudina et al. 2007; Tocchetti et al.
2012) and ob/ob mouse hearts (Boudina et al. 2005). On
the other hand, a recently published comprehensive longi-
tudinal metabolomics analysis on the interaction between
age and high-fat diet in the ob/ob mouse heart revealed
that mitochondrial function is largely preserved in ob/ob
mice fed with conventional rodent diet and defects in
both complex I and complex II only appeared as the mice
aged (10 months) (Wang et al. 2015). Switching to a
high-fat diet lead to a significant increase in respiratory
capacity when oxidizing fatty acids after 3 and 12 weeks
(Wang et al. 2015).
While mitochondrial respiration in the presence of sub-
strates feeding electrons into the electron transport system
was unchanged when expressed per mitochondrial mass,
the total oxidative phosphorylation in cardiac tissue is
also dependent on the mitochondrial content. Here, we
used several markers to estimate mitochondrial density,
namely CS activity, COX IV protein levels, and 2D TEM
analysis. All three methods showed that mitochondrial
content is reduced in early type-2 diabetic hearts of fruc-
tose-fed rats. Morphometric studies of cardiac mitochon-
dria in animal models of type-2 diabetes are very limited.
A mitochondrial biogenic response (increased number,
but somewhat smaller mitochondria) has been reported
to occur in the db/db mouse heart aged 8–9 weeks (Boud-
ina et al. 2007). However, at 18 weeks of age decreased
mitochondrial size as well as decreased state 3 respiration
rates were reported for subsarcolemmal mitochondria
(Dabkowski et al. 2010). In ob/ob mice aged 12 weeks a
qualitative examination revealed mitochondrial swelling
and cristae disorganization (Dong et al. 2006).
Figure 4. Sirtuin 1 (SIRT1) signaling in hearts of fructose-fed rats. (A) Representative immunoblot and densitometric analysis of nuclear SIRT1
level (n = 7/group). (B) Nuclear factor-jB (NF-jB) DNA-binding activity in cardiac tissues of control and fructose-fed rats, measured from nuclear
extracts (n = 6/group). (C) Nuclear SIRT1 activity and global acetylation profile of nuclear proteins (n = 6/group). The entire range (20–250 kDa)
of Ponceau Red-stained proteins was analyzed and used to normalize acetylated proteins (between 35 and 75 kDa) in respective lanes. (D)
Nuclear concentrations of NAD+ and NADH in cardiac tissues of control and fructose-fed rats, with their respective NAD+/NADH ratio (n = 8/
group). Results are mean  SE. #Mann–Whitney nonparametric statistical test was applied. C, control rats; FF, fructose-fed rats.
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Mitochondrial content and size reflect the interplay
between mitophagy (i.e., the degradation of existing,
potentially damaged, mitochondria), biogenesis, and
fusion/fission events. Generally speaking, mitochondria
can quickly adapt to changes in metabolic flux (Eisner
et al. 2017), but clearly much more work is necessary to
map morphological changes and fusion/fission events in
diabetic mitochondria.
Our experiments also revealed fatty acid remodeling in
cardiolipin. Cardiolipin is a membrane phospholipid
found predominantly in the inner mitochondrial mem-
brane. The symmetric form (tetralinoleoyl-CL or L4-CL)
is the most abundant in the mammalian heart (Schlame
et al. 2005). It is essential for optimal activities of individ-
ual respiratory system complexes and supercomplexes, of
ATP synthase and adenine nucleotide translocase (Para-
dies et al. 1837). Cardiolipin content and remodeling
changes the overall efficiency of the respiratory system
(Vergeade et al. 2016; Ye et al. 2016). In our study, we
observed alterations in cardiac cardiolipin fatty-acid spe-
cies composition, namely a loss of the symmetric tetrali-
noleoyl-CL in favor of more asymmetric cardiolipins with
shorter and more saturated chains (Fig. 2B, Table 6).
Similar cardiolipin abnormalities have been previously
reported to occur in ob/ob mouse hearts aged 12–
16 weeks (Han et al. 2007), however, the causes and the
bioenergetic consequences of these changes are largely
unknown and warrant further investigation.
Increased mitochondrial fatty acid oxidation exerts
pressure on the respiratory chain to reduce increasing
amounts of NADH and FADH2, leading to enhanced
ROS production (Fisher-Wellman and Neufer 2012; Rind-
ler et al. 2013). The following mechanisms are likely
responsible for the oxidative stress observed in hearts of
fructose-fed rats. First, superoxide production may
increase as a result of an enhanced complex I activity in
the absence of any corresponding increase in downstream
complex III activity. Second, excess in reducing equiva-
lents (i.e., NADH and FADH2) provided by enhanced
fatty acid oxidation increase the QH2/Q ratio, which con-
sequently increases ROS production by (1) limiting the
availability of oxidized Q as an electron acceptor for com-
plex I, (2) generating reverse electron transport back into
complex I, and/or (3) increasing the electron pressure at
complex III (Fisher-Wellman and Neufer 2012; Rindler
et al. 2013). This fatty acid oxidation-dependent ROS
generation may be a hallmark of T2DM and has been
reported to occur in the heart (Boudina et al. 2007; Wang
et al. 2015), skeletal muscle (Anderson et al. 2009b;
Seifert et al. 2010), and kidney (Rosca et al. 2012).
Figure 5. Sirtuin 3 (SIRT3) signaling in hearts of fructose-fed rats. Representative immunoblots and densitometric analyses of (A) mitochondrial
SIRT3 level (n = 7/group) and (B) global acetylation profile of mitochondrial proteins (n = 6/group). The entire range (20–250 kDa) of Ponceau
Red-stained proteins was analyzed and used to normalize acetylated proteins (between 35 and 75 kDa) in respective lanes. (C) Mitochondrial
concentrations of NAD+ and NADH in cardiac tissues of control and fructose-fed rats, with their respective NAD+/NADH ratio (n = 8/group). (D)
Mitochondrial SIRT3 activity (n = 6/group). Results are mean  SE. C, control rats; FF, fructose-fed rats.
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A reduced efficiency of ROS scavenging systems results
in a more oxidizing intracellular environment. Indeed,
the activity of the redox-sensitive TCA cycle enzyme
aconitase was reduced and we observed increased HNE-
modified mitochondrial proteins in hearts of fructose-fed
rats. Furthermore, both the GSH/GSSG ratio and
NADPH:NADP+ ratio were significantly reduced.
Increased cardiac oxidative stress has been observed in
ob/ob mice fed a high-fat diet (reduced GSH/GSSG ratio)
(Wang et al. 2015) and in db/db mice (increased HNE-
modified proteins and increased malondialdehyde levels)
(Boudina et al. 2007). It is important to note that in the
healthy heart, HNE -an aldehyde derivative generated
from lipid peroxidation- is readily metabolized by conju-
gation to glutathione (and subsequently removed by
aldose reductase) or by oxidation to 4-hydroxynonenoic
acid by aldehyde dehydrogenase (Srivastava et al. 1998).
Accumulation of HNE-protein adducts is therefore an
indicator of reduced glutathione availability, reduced
aldehyde dehydrogenase content, or depletion of NAD+,
an important cofactor determining aldehyde dehydroge-
nase activity. The activity of ALDH2 (mitochondrial iso-
form) was significantly reduced in cardiac mitochondria
from fructose-fed rats as compared to age-matched
healthy rats, consistent with increased formation of HNE-
adducts. The reasons for the impaired activity of ALDH2
are not clear, but it has been recently reported that HNE
forms adducts with ALDH2 itself and attenuates its activ-
ity (Mali et al. 2014). Surprisingly, mitochondrial NAD+
levels and the NAD+/NADH ratio were higher in hearts
from fructose-fed rats. However, the method used to
measure these metabolites cannot distinguish between
protein-bound and free NAD(H) and may not reflect the
availability of free NAD+.
Our results further suggest that the antioxidant
response in hearts of fructose-fed rats is perturbed, as evi-
denced by the unchanged activity of both MnSOD (the
primary mitochondrial antioxidant enzyme) and cytoplas-
mic CuZnSOD, both of which are responsible for the dis-
mutation of superoxide to H2O2. This occurs despite the
observed increase in NF-jB activity, known to regulate
the expression of several antioxidant proteins, including
MnSOD (reviewed in Morgan and Liu 2011). H2O2 can
alter the redox state of the cell by either reacting directly
with thiol residues within redox-sensitive proteins or by
shifting the GSH/GSSG ratio (Schafer and Buettner 2001).
Detoxification of H2O2 is achieved enzymatically by glu-
tathione peroxidases, catalase, and peroxiredoxins. We
found reduced abundance of GPx-1 that uses GSH as an
obligate cosubstrate in the reduction in H2O2 to water
and is the most important peroxidase for cellular H2O2
removal. In the heart, it is also a key enzyme responsible
for the removal of intramitochondrial peroxides (Antunes
et al. 2002). The thioredoxin-2 (Trx2) and GSH systems
function in parallel in peroxide metabolism (Zhang et al.
2007). The increased levels of TrxR2 (a central compo-
nent of the thioredoxin-2 system) may be thus interpreted
as a compensatory redox adaptive response, given that
the disulfide in the thioredoxin active site is reduced by
TrxR2 at the expense of NADPH, the levels of which are
significantly reduced in hearts from fructose-fed rats.
Increased protein levels of cardiac TrxR2 have been previ-
ously observed in mice on a high-fat, high-sugar diet
(Fisher-Wellman et al. 2013). In that study, the authors
also uncovered the critical role played by this enzyme in
suppressing mitochondrial H2O2 emission, specifically
during fatty acid oxidation (Fisher-Wellman et al. 2013).
Interestingly, our study demonstrates that nuclear
SIRT1 and mitochondrial SIRT3 protein levels (both
increased in cardiac tissue of fructose-fed rats) do not
adequately explain their respective changes in activity (re-
duced in the case of SIRT1 and unaffected, in the case of
SIRT3). Activation of PPARa can regulate SIRT1 expres-
sion in a positive manner (Hayashida et al. 2010). In
addition, an intricate crosstalk exists between NF-jB and
SIRT1 signaling (Kauppinen et al. 2013) affecting protein
levels. For instance, the expression of SIRT1 may increase
in NF-jB-driven inflammation (Zhang et al. 2010). In the
heart, a moderate increase in SIRT1 may serve to enhance
the tolerance to oxidative stress, as originally reported by
Alcendor et al. (2007). On the other hand, SIRT1 activa-
tion can inhibit NF-jB signaling either directly by
deacetylating the RelA/p65 subunit (Yeung et al. 2004) or
indirectly at the transcriptional level (Pfluger et al. 2008).
SIRT1 activity may be regulated directly or indirectly by a
number of different factors such as (Aguilar-Arnal et al.
2016) changes in free NAD+, (Alcendor et al. 2007) levels
of the inhibitor molecule nicotinamide (product inhibi-
tion), (Alrob et al. 2014) flux through the nicotinamide
salvage pathway, (Anderson et al. 2009a) oxidative modi-
fication of key residues required for catalysis. Very little is
known on the temporal evolution of SIRT1 activity in the
development and progression of cardiac insulin resistance.
Sulaiman et al. (2010) studied the temporal pattern of
SIRT1 activity in hearts of streptozotocin (STZ)-induced
type-1 diabetic in mice. Cardiac SIRT1 protein levels were
found to be significantly increased in the heart of diabetic
mice 1 month after STZ administration without any
changes in SIRT1 deacetylase activity. However, protein
levels were significantly reduced and activity severely
compromised in advanced type-1 diabetes (3 months fol-
lowing STZ injection) (Sulaiman et al. 2010). We specu-
late that increased protein levels of SIRT1 in fructose-fed
rats may represent an adaptive response to promote toler-
ance against oxidative stress. The concomitant decline in
activity could be the result of a decline in free NAD+ (as
2017 | Vol. 5 | Iss. 16 | e13388
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the method used to measure NADH and NAD+ cannot
distinguish between free and protein-bound nucleotides)
or could be due to oxidative posttranslational modifica-
tions. Indeed, there are studies indicating that the cysteine
residues in SIRT1 are vulnerable to oxidative and nitrosa-
tive stress, which lead to impaired sirtuin activity (Caito
et al. 2010; Zee et al. 2010; Shao et al. 2014).
Of the NAD-dependent lysine deacetylases present in
mitochondria (SIRT3, SIRT4, and SIRT5), only SIRT3
appears to regulate mitochondrial protein acetylation
levels (Hirschey et al. 2011; Bugger et al. 2016). Our
results show increased SIRT3 protein levels in cardiac
mitochondria from fructose-fed rat as compared to rats
fed a standard diet. In the study by Hirschey and co-
workers (Hirschey et al. 2011), feeding mice a high-fat
diet for 13 weeks reduced liver SIRT3 protein content
and significantly increased hepatic mitochondrial protein
acetylation as compared to mice fed standard diet. The
authors attributed the loss of SIRT3 protein to the reduc-
tion in PGC-1a, a known regulator of SIRT3 (Kong et al.
2010). A similar reduction in SIRT3 levels has been
observed in the heart (Alrob et al. 2014; Zeng et al.
2015), although the authors of those studies did not
investigate potential mechanisms. Moreover, there may
have been a biasing interaction between chronic high-fat
feeding and aging in the mentioned studies (Kwon et al.
2015). It is interesting to note that chronic caloric restric-
tion results in a dramatically different and tissue-depen-
dent regulation of mitochondrial acetylation (Schwer
et al. 2009). The authors found that protein acetylation
was significantly increased in liver mitochondria (despite
a moderate increase in SIRT3 protein levels), significantly
decreased in brown adipose tissue, but almost unaffected
in heart, kidney, and brain (Schwer et al. 2009). In our
study (short-term fructose feeding), we think that the
increased cardiac SIRT3 protein levels may be explained
by increased activity of PGC-1a. Despite increased protein
levels, SIRT3 deacetylase activity was unaffected by fruc-
tose feeding and the acetylation pattern of mitochondrial
proteins was similar in hearts from fructose-fed rats as
compared to healthy age-matched rats. We speculate that
the increased protein levels may represent an adaptive
response to either a decrease in free NAD+, despite
increased activity of complex I and related regeneration
of NAD+ (the total levels of which are increased in car-
diac mitochondria from fructose-fed rats), or SIRT3 car-
bonylation, which has been shown to negatively affect its
activity (Fritz et al. 2011). Indeed, sirtuins are important
in facilitating metabolic adaptations to nutritional stress
(caloric restriction and overnutrition). However, our data
clearly indicate that sirtuin protein abundance does not
necessarily mirror activity and that more research is
needed to really dissect the regulatory pathways leading
to changes in protein acetylation and function both in
health and disease. Novel tools that allow more accurate
measurements of free NAD+ concentrations in different
cellular compartments have been recently become avail-
able and indeed reveal the complexities of NAD+ signal-
ing (Aguilar-Arnal et al. 2016; Cambronne et al. 2016).
In conclusion, our study supports the important role
of SIRT1-PPARa signaling in cardiac metabolic adapta-
tions in early T2DM by modulating the fatty acid oxida-
tion pathway. The observed decreased activity of cardiac
SIRT1 after 6 weeks of fructose feeding may indicate that
the heart is no longer capable to cope with the chronic
increased availability of lipids. This may represent one of
the earliest events in the development of biochemical
derangements that will ultimately lead to inflammation
and remodeling in the diabetic heart.
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